C

Clinical Outcomes of Liposomal Irinotecan+ 5-FU/LV for mPAC in Patients Previously Treated With Conventional Irinotecan-Containing Chemotherapy

By Changhoon Yoo 2 Videos
367 views
June 23, 2021
0 Comments
Login to view comments. Click here to Login

Featured Video

10:25
Exelixis

Explore the mechanism of Action of a TKI in HCC

Feat. W. Keiser

Featured Video

20:00
Exelixis

Child-Pugh Classification and its Role in Treatment Decisions in Pat…

Feat. P. Gholam

Related Content

AUTOPLAY
27:37
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Expert Panel Discussion: Practice-Changing Updates

Feat. N. Uboha, A. Turk, K. Spencer, M. Cecchini
23:58
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Key Studies

Feat. R. Kim, R. Mehta
20:07
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "GI Expert Panel Discussion on Key Trials I…

Feat. Y. Janjigian, S. Cytryn, S. Maron
03:50
UCLA Health

Perspectives on the Recent FDA Approval of NALIRIFOX in Frontline Me…

Feat. Z. Wainberg
12:08
Yale Cancer Center

GI Oncology Year in Review: Precision Medicine Update in Metastatic …

Feat. J. Lacy
07:53
Total Health

Updates on Pancreatic Cancer - 2023 ASCO® Direct Philadelphia

Feat. D. Lin
30:55
2023 Johns Hopkins Updates in Gastrointestinal Cancers

Medical Oncology Updates in Pancreas Cancer

Feat. T. Bekaii-Saab
06:28
Shubham Pant

FDA Approval of Liposomal Irinotecan/NALIRIFOX in 1L Metastatic Panc…

17:05
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "A Multicenter, Randomized, Open-Label, Thr…

Feat. A. Ohba
22:10
Yale Cancer Center

Pancreatic Cancer Updates From Yale Cancer Center

Feat. J. Lacy
08:08
Integrity Continuing Education

Updates in Nonmetastatic Upper-GI Adenocarcinoma

Feat. J. Hernandez
25:56
OncoAlert

Year in Review: Pancreatic Cancers

Feat. M. Lewis
10:53
Yale Cancer Center

GI Oncology Year in Review: Metastatic Pancreatic Cancer - NAPOLI-3 …

Feat. J. Lacy
18:35
Rachna Shroff

Augmenting Standard Treatment Options in Pancreatic Cancer

15:25
Scripps MD Anderson Cancer Center

Pancreatic Cancer Trials - Evolving Landscape and Treatment Guidance

Feat. J. Hecht
07:42
Integrity Continuing Education

Debates in Neoadjuvant Therapy in Resectable Pancreatic Cancer: Why …

Feat. W. Burns
06:16
ecancer

ASCO® 2023 Insights: "NAPOLI 3 Analysis of 1L NALIRIFOX vs. Gem…

Feat. E. O’Reilly
10:41
ASCO GI 2023 Conference Coverage

ASCO GI 2023 NAPOLI-3 Randomized, Open-Label Phase 3 Study: Liposoma…

Feat. Z. Wainberg
08:03
Insights from 2023 ESMO World Congress on Gastrointestinal Cancer Annual Meeting

2023 ESMO WCGIC Insights: "Additional Results From the Phase 3 …

Feat. Z. Wainberg
23:32
The University of Kansas Cancer Center

Updates on Pancreatic Cancer Treatment

Feat. A. Kasi